Similar to SOX9, ANXA2P2 expression was dramatically upregulated in DDP-resistant Caski/DDP and HeLa/DDP cells compared with that in original Caski and HeLa cells (Figure 5E), and upregulated in DDP-resistant cervical cancer tissues compared to those in non-resistant samples (Figure 5F). This evidence concerns the gene ANXA2P2 and cervical cancer.